Skip to Main Content

Paper Details

SPOP mutation leads to genomic instability in prostate cancer.
Elife
137
2015
BRCA1, DSB, PARP, SPOP, cancer, genome, human, mutant SPOP, primary prostate cancer, prostate cancer
Author NameAffiliation
Gunther BoysenWeill Cornell Medical College
Gunther Boysen
Gunther BoysenDivision of Clinical Studies, Institute of Cancer Research
Christopher E BarbieriWeill Cornell Medical College
Christopher E BarbieriSandra and Edward Meyer Cancer Center, Weill Cornell Medical College
Christopher E BarbieriWeill Cornell Medical College
Christopher E BarbieriSandra and Edward Meyer Cancer Center, Weill Cornell Medical College
Davide PrandiUniversity of Trento
Davide PrandiUniversity of Trento
Mirjam BlattnerWeill Cornell Medical College
Sung-Suk ChaeWeill Cornell Medical College
Clarisse MarotzWeill Cornell Medical College
Andrea SbonerWeill Cornell Medical College
Andrea SbonerInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
Andrea SbonerHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerWeill Cornell Medical College
Andrea SbonerHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
Johann S de BonoDivision of Clinical Studies, Institute of Cancer Research
Johann S de Bono
Francesca DemichelisUniversity of Trento
Francesca DemichelisInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
Francesca DemichelisHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Francesca DemichelisUniversity of Trento
Francesca DemichelisHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Francesca DemichelisInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College
Mark A RubinSandra and Edward Meyer Cancer Center, Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College
Mark A RubinInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College
Mark A RubinSandra and Edward Meyer Cancer Center, Weill Cornell Medical College
Mark A RubinWeill Cornell Medical College
Mark A RubinInstitute for Precision Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College
  • 1 - 34

Datasets